In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute.

Megan M Allyn, Annie K Ryan, Grace Rivera, Esther Mamo, Joshua Bopp, Sebastian Martinez Hernandez, Julie Racine, Eric J Miller, Heather L Chandler, Katelyn E Swindle-Reilly
{"title":"In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute.","authors":"Megan M Allyn, Annie K Ryan, Grace Rivera, Esther Mamo, Joshua Bopp, Sebastian Martinez Hernandez, Julie Racine, Eric J Miller, Heather L Chandler, Katelyn E Swindle-Reilly","doi":"10.1002/jbm.a.37813","DOIUrl":null,"url":null,"abstract":"<p><p>The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye. The purpose of this study was to evaluate antioxidant-loaded hydrogel vitreous substitutes in a pilot in vivo study. Ascorbic acid and glutathione were loaded into synthesized PEGDA hydrogels. Following vitrectomy, experimental antioxidant hydrogels or silicone oil were injected into one eye of rabbits, while the other eye served as untreated or sham control. Ophthalmic assessments, including electroretinography, were performed. Levels of glutathione and ascorbic acid were higher in the eyes treated with the antioxidant-loaded hydrogel vitreous substitute, although this was not found to be significant after 28 days. There were no statistically significant differences between groups with respect to clinical examination, and ocular health scores, electroretinograms, and histology were normal. These results indicate minimal concerns for the hydrogel formulation or high levels of antioxidants. Future research will assess the capability of vitreous substitutes to prolong antioxidant release, with the goal of minimizing cataract after vitrectomy.</p>","PeriodicalId":94066,"journal":{"name":"Journal of biomedical materials research. Part A","volume":" ","pages":"e37813"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jbm.a.37813","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye. The purpose of this study was to evaluate antioxidant-loaded hydrogel vitreous substitutes in a pilot in vivo study. Ascorbic acid and glutathione were loaded into synthesized PEGDA hydrogels. Following vitrectomy, experimental antioxidant hydrogels or silicone oil were injected into one eye of rabbits, while the other eye served as untreated or sham control. Ophthalmic assessments, including electroretinography, were performed. Levels of glutathione and ascorbic acid were higher in the eyes treated with the antioxidant-loaded hydrogel vitreous substitute, although this was not found to be significant after 28 days. There were no statistically significant differences between groups with respect to clinical examination, and ocular health scores, electroretinograms, and histology were normal. These results indicate minimal concerns for the hydrogel formulation or high levels of antioxidants. Future research will assess the capability of vitreous substitutes to prolong antioxidant release, with the goal of minimizing cataract after vitrectomy.

抗氧化水凝胶玻璃体替代物的体内评估
随着年龄的增长,玻璃体会发生液化,从而导致并发症,可能需要进行玻璃体切除术,即通过手术将玻璃体从眼球中取出。硅油是一种常见的玻璃体替代物,但它缺乏与天然玻璃体相似的特性。特别是,它缺乏减少眼内氧化应激所需的抗氧化剂。本研究的目的是在一项试验性体内研究中对抗氧化剂水凝胶玻璃体替代物进行评估。在合成的 PEGDA 水凝胶中添加了抗坏血酸和谷胱甘肽。玻璃体切除术后,将实验性抗氧化剂水凝胶或硅油注入兔子的一只眼睛,另一只眼睛作为未处理或假对照。进行眼科评估,包括视网膜电图。接受抗氧化剂水凝胶玻璃体替代物治疗的兔子眼睛中谷胱甘肽和抗坏血酸的含量较高,但在 28 天后这一结果并不显著。在临床检查方面,各组之间没有明显的统计学差异,眼部健康评分、视网膜电图和组织学均正常。这些结果表明,对水凝胶配方或高水平抗氧化剂的担忧微乎其微。未来的研究将评估玻璃体替代物延长抗氧化剂释放时间的能力,目的是最大限度地减少玻璃体切除术后的白内障。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信